Lopres 50 mg Tablet contains atenolol, a beta-blocker that slows the heart and reduces its workload. It is used for high blood pressure, angina, and after certain heart attacks, as prescribed by a doctor.
There are 59 brands of Atenolol listed in Bangladesh. 40 of them have a lower unit price than Lopres. The lowest listed price is Betanol 25 mg Tablet at ৳ 0.45 per unit.
What is Lopres 50 mg Tablet?
Lopres 50 mg Tablet is a medicine that belongs to a group called beta-adrenoceptor blocking drugs. Its active ingredient, atenolol, works mainly on the heart by blocking certain signals that make the heart beat faster and harder. This helps lower blood pressure and reduces the heart's oxygen demand. Doctors prescribe it for high blood pressure, for long-term management of angina (chest pain from heart disease), and for some patients after a heart attack to lower the risk of death from heart problems. It is available only on prescription, and the doctor decides how long you need to take it.
Uses of Lopres
Lopres 50 mg Tablet is used to treat high blood pressure, often alone or with other blood pressure medicines such as thiazide diuretics. It is also used for the long-term management of angina pectoris, helping to reduce the frequency of chest pain. In some patients with a confirmed or suspected acute heart attack, it may be used to reduce the risk of death from cardiovascular causes. Your doctor will determine if this medicine is suitable for your condition.
How to use Lopres
Lopres 50 mg Tablet is taken by mouth. The doctor decides the exact dose and how often you take it, based on your condition and response. Swallow the tablet with water, with or without food, as your doctor advises. Do not change the dose or stop taking it on your own, because stopping suddenly can worsen your condition. If you miss a dose, ask your doctor or pharmacist what to do. Always follow the prescription and keep taking it regularly.
Side effects of Lopres
Like all beta-blockers, Lopres 50 mg Tablet can cause side effects. The most common are a slow heart rate (bradycardia) and low blood pressure (hypotension), especially when used after a heart attack. Other possible effects reported with beta-blockers include tiredness, dizziness, cold hands and feet, sleep problems, and mood changes. Allergic reactions such as fever, sore throat, or breathing difficulty can occur. If you notice any unusual symptoms, contact your doctor promptly. Do not stop the medicine without medical advice.
Safety and precautions
Lopres 50 mg Tablet is not suitable for everyone. It should not be used if you have certain heart rhythm problems (such as sinus bradycardia or heart block greater than first degree), cardiogenic shock, overt heart failure, or an allergy to atenolol or any ingredient. Tell your doctor if you have kidney problems, poor circulation in the legs, or are already taking another beta-blocker. In pregnancy, atenolol is in category D, meaning it may pose a risk to the fetus; caution is needed. It passes into breast milk and can cause slow heart rate in breast-fed infants, especially premature or those with kidney problems. Always consult your doctor before use.
Frequently asked questions
Is Lopres 50 mg Tablet safe during pregnancy or breastfeeding?
Atenolol, the active ingredient, is pregnancy category D, so it may harm the fetus and should only be used if the doctor decides it is necessary. It also passes into breast milk and can cause slow heart rate in breast-fed babies. Always ask your doctor before taking it if you are pregnant, planning pregnancy, or breastfeeding.
What is Lopres 50 mg Tablet used for and what kind of medicine is it?
Lopres 50 mg Tablet is a beta-blocker (beta-adrenoceptor blocking drug) containing atenolol. It is used to treat high blood pressure, for long-term management of angina (chest pain), and in some patients after a heart attack to reduce the risk of death from heart problems. It works by slowing the heart and reducing its workload.
How should Lopres 50 mg Tablet be taken?
Take Lopres 50 mg Tablet by mouth exactly as your doctor prescribes. The dose and how often you take it are decided by your doctor based on your condition. Do not change the dose or stop taking it without consulting your doctor, as sudden stopping can be harmful. If you miss a dose, ask your doctor or pharmacist for advice.
In the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
For the long-term management of patients with angina pectoris.
In the management of hemodynamically stable patients with defnite or suspected acute myocardial infarction to reduce cardiovascular mortality.
Pharmacology
The synthesis of atenolol resulted from attempts to produce a β-adrenoceptor antagonist that would competitively block β1 (cardiac) receptors but have no effect on β2-receptors. It is classified as a β1 selective (cardioselective) β-adrenergic receptor antagonist with no membranestability activity and no partial agonist activity. It is markedly the most hydrophilic of the currently available β- blockers and thus penetrates the lipid of cell membranes poorly
Dosage & Administration
Hypertension: The initial dose of Atenolol is 50 mg given as one tablet a day either alone or added to diuretic therapy. The full effect of this dose will usually be seen within one to two weeks. If an optimal response is not achieved, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Increasing the dosage beyond 100 mg a day is unlikely to produce any further benefit.
Angina Pectoris: The initial dose of Atenolol is 50 mg given as one tablet a day. If an optimal response is not achieved within one week, the dosage should be increased to Atenolol 100 mg given as one tablet a day. Some patients may require a dosage of 200 mg once a day for optimal effect. Twenty-four hour control with once daily dosing is achieved by giving doses larger than necessary to achieve an immediate maximum effect. The maximum early effect on exercise tolerance occurs with doses of 50 to 100 mg, but at these doses the effect at 24 hours is attenuated, averaging about 50% to 75% of that observed with once a day oral doses of 200 mg.
Acute Myocardial Infarction: In patients with definite or suspected acute myocardial infarction, treatment with Atenolol I.V. Injection should be initiated as soon as possible after the patient's arrival in the hospital and after eligibility is established. Treatment should begin with the intravenous administration of 5 mg Atenolol over 5 minutes followed by another 5 mg intravenous injection 10 minutes later. In patients who tolerate the full intravenous dose (10 mg), Atenolol Tablets 50 mg should be initiated 10 minutes after the last intravenous dose followed by another 50 mg oral dose 12 hours later. Thereafter, Atenolol can be given orally either 100 mg once daily or 50 mg twice a day for a further 6-9 days or until discharge from the hospital. If bradycardia or hypotension requiring treatment or any other untoward effects occur, Atenolol should be discontinued.
Interaction
Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents. Patients treated with Atenolol plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension.
Calcium channel blockers may also have an additive effect when given with Atenolol.
Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects. Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers.
Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.
Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine. If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped.
Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers.
While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.
Contraindications
Atenolol is contraindicated in-
Sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure.
Those patients with a history of hypersensitivity to the atenolol or any of the drug product’s components.
Side Effects
In a series of investigations in the treatment of acute myocardial infarction, bradycardia and hypotension occurred more commonly, as expected for any beta blocker. In addition, a variety of adverse efects has been reported with other beta-adrenergic blocking agents, and may be considered potential adverse efects of Atenolol.
Hematologic: Agranulocytosis.
Allergic: Fever, combined with aching and sore throat, laryngospasm, and respiratory distress.
Central Nervous System: Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation of time and place; short term memory loss; emotional lability with slightly clouded sensorium; and, decreased performance on neuropsychometrics.
Miscellaneous: There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs. Discontinuance of the drug should be considered if any such reaction is not otherwise explicable. Patients should be closely monitored following cessation of therapy.
Other: Erythematous rash
Pregnancy & Lactation
Pregnancy Category D. Caution should be exercised when Atenolol is administered to a nursing woman. Clinically significant bradycardia has been reported in breast-fed infants. Premature infants, or infants with impaired renal function, may be more likely to develop adverse effects.
Precautions & Warnings
General: Patients already on a beta blocker must be evaluated carefully before Atenolol is administered. Initial and subsequent Atenolol dosages can be adjusted downward depending on clinical observations including pulse and blood pressure. Atenolol may aggravate peripheral arterial circulatory disorders.
Impaired Renal Function: The drug should be used with caution in patients with impaired renal function.
Geriatric Use:
Hypertension and Angina Pectoris: Due to Coronary Atherosclerosis: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Acute Myocardial Infarction: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.
Overdose Effects
Overdosage with Atenolol has been reported with patients surviving acute doses as high as 5 g. One death was reported in a man who may have taken as much as 10 g acutely. The predominant symptoms reported following Atenolol overdose are lethargy, disorder of respiratory drive, wheezing, sinus pause and bradycardia. Additionally, common efects associated with overdosage of any beta-adrenergic blocking agent and which might also be expected in Atenolol overdose are congestive heart failure, hypotension, bronchospasm and/or hypoglycemia. Treatment of overdose should be directed to the removal of any unabsorbed drug by induced emesis, gastric lavage, or administration of activated charcoal. Atenolol can be removed from the general circulation by hemodialysis. Based on the severity of symptoms, management may require intensive support care and facilities for applying cardiac and respiratory support.
Storage Conditions
Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician.
Alternative brands of Atenolol
Other brands with the same generic name, cheapest first.